Table 1.
Patient characteristics and laboratory data at baseline.
Table 2.
Logistic regression data for association of sICAM-1 and anti-VSA antibodies with CM.
Figure 1.
Acute and convalescent levels of antibodies to ICAM-1 selected parasites.
Symbols linked by straight line represent anti-VSA antibody levels on days 0 and 7 for individual participants.
Figure 2.
Acute and convalescent levels of antibodies to CD36- selected parasites.
Symbols linked by straight line represent anti-VSA antibody levels on days 0 and 7 for individual participants.
Table 3.
Comparison of anti-CD36 and anti-CD54 antibody levels between D0 and D7 samples for CM and UM patients.